Insulin degludec in a flexible daily dosing regimen provides similar glycaemic control without increasing rates of hypoglycaemia compared to dosing the same time daily in type 2 diabetes

Detalhes bibliográficos
Principais autores:	Birkeland, K, Raz, I, Gough, S, Atkin, S, Shestakova, M, Blonde, L, Meneghini, L, Begtrup, K, Johansen, T, Bain, S
Formato:	Conference item
Publicado em:	2011

Registros relacionados